SEC Form 4 · accession 0001140361-15-020974
BIOMARIN PHARMACEUTICAL INC · BMRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George Eric Davis
Officer — SVP, General Counsel
Period of report
May 15, 2015
Accepted (ET)
May 19, 2015 · 7:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001048477
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 15, 2015 | F | 1,096 | $122.78 | D | 71,784 | D | |
| Common StockF1 | May 18, 2015 | S | 2,558 | $125.26 | D | 69,226 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1All shares sold at same price.